ASHPOfficial

Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, pharmacy technicians discuss the Standardize 4 Safety initiative and how it impacts the role of the technician in medication preparation and patient safety.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The CDC has provided a lot of guidance surrounding COVID-19 vaccine boosters and there are several vaccine manufacturers of these vaccines. How do we make sense of this information to ensure patients receive appropriate, evidence-based protection? This podcast will describe supplementary guidance for mixing and matching COVID-19 vaccine boosters by evaluating the literature and also reviewing current CDC recommendations. 

Due to ongoing updates, please see the CDC’s COVID-19 Vaccine Interim Immunization Schedule for Ages 6 Months and Older here: https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-immunization-schedule-ages-6months-older.pdf  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Nilay Shah and Dr. Eric Tichy discuss the AJHP Special Feature, “National trends in prescription drug expenditures and projections for 2022,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our pharmacists who practice in small and rural hospital share best practices for engaging and training pharmacists to use video conferencing technology, identify resources and strategies for developing telepharmacy services and how telepharmacy post COVID can advance pharmacy practice and improve patient care. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listeners will be introduced to the background and purpose of the Specialty Pharmacy Outcomes Literature Library, an exciting new resource for ASHP members. This podcast will also discuss how best to utilize this resource as members set out to perform their own outcomes projects.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this first of a series, Vicki Basalyga, Director of Member Relations at ASHP and ASHP representative for the Navigators, sits down with the leaders of the group to discuss their mission, vision and the goals of this group as they relate to public health.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, produced by ASHP’s Pharmacy Administration and Leadership Resident Collaborative, provides an engaging interview with two pharmacy leaders who have had successful careers after completing a Health System Pharmacy Administration and Leadership residency. Although both leaders have completed the same type of residency training, they have pursued different career paths, one being traditional and the other being non-traditional. David Dawka and Samm Anderegg will share their insights on their professional journeys after residency.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this pediatric-focused presentation planned in cooperation with the Section of Clinical Specialists and Scientists, our content matter expert reviews the neonatal and pediatric requirements for macronutrients and micronutrients and the characteristics of this population’s specific parenteral nutrition products affect the solubility and stability of the formulation. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Finding and engaging a mentor can be one of the most intimidating and challenging parts of pharmacy school. During this podcast, Megan Wright, PharmD Candidate at the UNC Eshelman School of Pharmacy and Dr. Katelynn Granger, a PGY-1 resident at MUSC Health, will talk discuss their own personal mentorship relationship and how it can be fostered and maintained through busy times.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.